IN192932B - - Google Patents

Info

Publication number
IN192932B
IN192932B IN43MU2000A IN192932B IN 192932 B IN192932 B IN 192932B IN 43MU2000 A IN43MU2000 A IN 43MU2000A IN 192932 B IN192932 B IN 192932B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Alfons Grunenberg
Karlheinz Wahl
Klaus-Peter Voges
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of IN192932B publication Critical patent/IN192932B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN43MU2000 1997-12-24 1998-12-24 IN192932B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)

Publications (1)

Publication Number Publication Date
IN192932B true IN192932B (en:Method) 2004-06-12

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
IN43MU2000 IN192932B (en:Method) 1997-12-24 1998-12-24

Country Status (36)

Country Link
US (1) US6362214B1 (en:Method)
EP (1) EP1051398B1 (en:Method)
JP (2) JP3817668B2 (en:Method)
KR (1) KR100586350B1 (en:Method)
CN (1) CN1140510C (en:Method)
AR (1) AR013803A1 (en:Method)
AT (1) ATE263152T1 (en:Method)
AU (1) AU744242B2 (en:Method)
BG (1) BG65024B1 (en:Method)
BR (1) BR9814496A (en:Method)
CA (1) CA2313230A1 (en:Method)
CO (1) CO4970800A1 (en:Method)
DE (2) DE19757983A1 (en:Method)
DK (1) DK1051398T3 (en:Method)
ES (1) ES2218874T3 (en:Method)
GT (1) GT199800198A (en:Method)
HN (1) HN1998000186A (en:Method)
HU (1) HUP0004432A3 (en:Method)
ID (1) ID25446A (en:Method)
IL (1) IL136278A (en:Method)
IN (1) IN192932B (en:Method)
MY (1) MY116312A (en:Method)
NO (1) NO316618B1 (en:Method)
NZ (1) NZ504741A (en:Method)
PE (1) PE20000115A1 (en:Method)
PL (1) PL341359A1 (en:Method)
PT (1) PT1051398E (en:Method)
RU (1) RU2220137C2 (en:Method)
SI (1) SI1051398T1 (en:Method)
SK (1) SK285109B6 (en:Method)
TR (1) TR200001936T2 (en:Method)
TW (1) TW552258B (en:Method)
UA (1) UA66832C2 (en:Method)
UY (2) UY25324A1 (en:Method)
WO (1) WO1999033803A1 (en:Method)
ZA (1) ZA9811817B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2107907B1 (en) * 2006-12-20 2012-02-01 Cardoz AB Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders
US20100099693A1 (en) * 2007-01-16 2010-04-22 Johan Raud New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
EP4420734A3 (en) 2015-02-13 2024-11-06 Institut National de la Santé et de la Recherche Médicale Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557665A (en) * 1975-12-10 1979-12-12 Ici Ltd Process for the manufacture of a carboxyalkylamino anthraquinone compounds
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use
CN1015711B (zh) * 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) * 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
DE19506739A1 (de) * 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
EP1051398A1 (en) 2000-11-15
PE20000115A1 (es) 2000-03-26
NO20003217L (no) 2000-06-21
KR100586350B1 (ko) 2006-06-07
AU1687499A (en) 1999-07-19
MY116312A (en) 2003-12-31
ZA9811817B (en) 1999-06-29
NZ504741A (en) 2002-10-25
JP3817668B2 (ja) 2006-09-06
DE69822882T2 (de) 2005-02-03
SK285109B6 (sk) 2006-06-01
WO1999033803A1 (en) 1999-07-08
JP4411269B2 (ja) 2010-02-10
AR013803A1 (es) 2001-01-10
ES2218874T3 (es) 2004-11-16
EP1051398B1 (en) 2004-03-31
CA2313230A1 (en) 1999-07-08
JP2006151977A (ja) 2006-06-15
IL136278A (en) 2005-03-20
TR200001936T2 (tr) 2001-01-22
HUP0004432A3 (en) 2002-10-28
UA66832C2 (uk) 2004-06-15
KR20010033529A (ko) 2001-04-25
ID25446A (id) 2000-10-05
UY25324A1 (es) 2000-12-29
TW552258B (en) 2003-09-11
ATE263152T1 (de) 2004-04-15
NO316618B1 (no) 2004-03-08
BG65024B1 (bg) 2006-12-29
HK1034517A1 (en) 2001-10-26
DE69822882D1 (en) 2004-05-06
UY25575A1 (es) 1999-11-17
HUP0004432A2 (hu) 2001-06-28
CO4970800A1 (es) 2000-11-07
SI1051398T1 (en) 2004-08-31
US6362214B1 (en) 2002-03-26
JP2001527067A (ja) 2001-12-25
SK9752000A3 (en) 2001-02-12
CN1282320A (zh) 2001-01-31
NO20003217D0 (no) 2000-06-21
PT1051398E (pt) 2004-07-30
GT199800198A (es) 1998-12-15
HN1998000186A (es) 1999-11-03
AU744242B2 (en) 2002-02-21
BR9814496A (pt) 2000-10-10
CN1140510C (zh) 2004-03-03
BG104554A (en) 2001-05-31
IL136278A0 (en) 2001-05-20
DE19757983A1 (de) 1999-07-01
DK1051398T3 (da) 2004-07-19
RU2220137C2 (ru) 2003-12-27
PL341359A1 (en) 2001-04-09

Similar Documents

Publication Publication Date Title
ITMI971385A0 (en:Method)
FR10C0039I1 (en:Method)
ITTO970573A0 (en:Method)
IN192932B (en:Method)
IN190887B (en:Method)
ITMI970489V0 (en:Method)
ITMI971567A0 (en:Method)
ITMI971506A0 (en:Method)
ITRM970098V0 (en:Method)
ITMI970299V0 (en:Method)
ITCH970006A0 (en:Method)
IN185486B (en:Method)
IN183753B (en:Method)
IN183748B (en:Method)
IN183691B (en:Method)
ITTO970461A0 (en:Method)
CN3058462S (en:Method)
CN3057977S (en:Method)
CN3067119S (en:Method)
CN3058984S (en:Method)
CN3058923S (en:Method)
CN3058533S (en:Method)
CN3058531S (en:Method)
CN3058000S (en:Method)
CN3057976S (en:Method)